Published in

Elsevier, EBioMedicine, (98), p. 104878, 2023

DOI: 10.1016/j.ebiom.2023.104878

Links

Tools

Export citation

Search in Google Scholar

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster

Journal article published in 2023 by Terry M. Nolan ORCID, Georgia Deliyannis ORCID, Maryanne Griffith, Sabine Braat ORCID, Lilith F. Allen, Jennifer Audsley, Amy W. Chung, Marcin Ciula, Nicholas A. Gherardin, Michelle L. Giles, Tom P. Gordon, Samantha L. Grimley, Lana Horng, David C. Jackson, Jennifer A. Juno ORCID and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO